AbbVie has moved to shore up its pipeline following the loss of patent protection for its top ... if it goes through - would be headed by Elahere (mirvetuximab soravtansine) for the treatment ...

Kim Kardashian was one of many stars in attendance a the Caring for Women Dinner hosted by The Kering Foundation in New York ...

Kamala Harris took the stage at The Congressional Black Caucus Foundation's 53rd Annual Legislative Conference Phoenix Awards ...

According to the company, Elahere stood out ... However, because of elevated growth expectations, no major pending patent losses, and the "soft landing" from Humira, I believe a higher valuation ...

The mom of multiple began her modeling career on the runway when she was just 14 after being discovered through IMG Models' ...

Can you picture a RAM with comfy seats for seven passengers? Stellantis' new patent is heading in that direction. Let's dive ...

The company's leaders expertly positioned it for Humira's loss of patent protection ... and its commercial-stage cancer treatment drug, Elahere. AbbVie expects Elahere to be approved for ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's patent rights in nerve-stimulation technology. Samsung Electronics owes an ...

Standouts (and sure-to-sell-outs) included tailored blazer-dresses, patent-leather trenches, and elevated baseball jerseys ...

Fashion month is in full swing, and with New York and London behind us, it’s on to MFW. Prada remains one of the week’s most ...

Survey questions include eye contact, social interaction, anxiety, etc. Ludwig acquired the following: U.S. Patent Application 18/705375, International Publication Number WO 2023/077245 ...

THE budget retailer has done it once again when it comes to making designer dupes at a fraction of the price. This time, Primark has launched a dupe of the cult-favourite Ganni buckle-shoe.